These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6142893)

  • 41. Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Mol Membr Biol; 1996; 13(1):1-17. PubMed ID: 9147657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding properties of agonists and antagonists to distinct allosteric states of the nicotinic acetylcholine receptor are incompatible with a concerted model.
    Krauss M; Korr D; Herrmann A; Hucho F
    J Biol Chem; 2000 Sep; 275(39):30196-201. PubMed ID: 10900197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Agonist-induced displacement of quinacrine from its binding site on the nicotinic acetylcholine receptor: plausible agonist membrane partitioning mechanism.
    Arias HR
    Mol Membr Biol; 1995; 12(4):339-47. PubMed ID: 8747279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Orientation of cobra alpha-toxin on the nicotinic acetylcholine receptor. Fluorescence studies.
    Johnson DA; Cushman R; Malekzadeh R
    J Biol Chem; 1990 May; 265(13):7360-8. PubMed ID: 2110165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of pairwise interactions in the alpha-neurotoxin-nicotinic acetylcholine receptor complex through double mutant cycles.
    Ackermann EJ; Ang ET; Kanter JR; Tsigelny I; Taylor P
    J Biol Chem; 1998 May; 273(18):10958-64. PubMed ID: 9556574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects.
    Zwart R; Vijverberg HP
    Mol Pharmacol; 1997 Nov; 52(5):886-95. PubMed ID: 9351980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of antibiotics on agonist occupation and functional states of the nicotinic acetylcholine receptor.
    Brown RD; Taylor P
    Mol Pharmacol; 1983 Jan; 23(1):8-16. PubMed ID: 6306428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1996 Sep; 333(1):1-11. PubMed ID: 8806747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photoaffinity labeling of the acetylcholine binding sites on the nicotinic receptor by an aryldiazonium derivative.
    Langenbuch-Cachat J; Bon C; Mulle C; Goeldner M; Hirth C; Changeux JP
    Biochemistry; 1988 Apr; 27(7):2337-45. PubMed ID: 2454653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromocytoma or the TE671/RD human clonal line.
    Lukas RJ
    J Neurochem; 1991 Apr; 56(4):1134-45. PubMed ID: 2002334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
    Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors.
    Fletcher GH; Steinbach JH
    Mol Pharmacol; 1996 May; 49(5):938-47. PubMed ID: 8622644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is agonist self-inhibition at the nicotinic acetylcholine receptor a nonspecific action?
    Forman SA; Firestone LL; Miller KW
    Biochemistry; 1987 May; 26(10):2807-14. PubMed ID: 3038165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular basis of the two nonequivalent ligand binding sites of the muscle nicotinic acetylcholine receptor.
    Blount P; Merlie JP
    Neuron; 1989 Sep; 3(3):349-57. PubMed ID: 2642001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Permeability control by cholinergic receptors in Torpedo postsynaptic membranes: agonist dose-response relations measured at second and millisecond times.
    Neubig RR; Cohen JB
    Biochemistry; 1980 Jun; 19(12):2770-9. PubMed ID: 7397104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells.
    Storch A; Schrattenholz A; Cooper JC; Abdel Ghani EM; Gutbrod O; Weber KH; Reinhardt S; Lobron C; Hermsen B; Soskiç V
    Eur J Pharmacol; 1995 Aug; 290(3):207-19. PubMed ID: 7589215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
    Whiteaker P; Sharples CG; Wonnacott S
    Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonequivalence of alpha-bungarotoxin binding sites in the native nicotinic receptor molecule.
    Conti-Tronconi BM; Tang F; Walgrave S; Gallagher W
    Biochemistry; 1990 Jan; 29(4):1046-54. PubMed ID: 2340276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Marked up-regulation of the beta-bungarotoxin site in adrenal chromaffin cells by specific nicotinic antagonists.
    Quik M; Geertsen S; Trifaró JM
    Mol Pharmacol; 1987 Apr; 31(4):385-91. PubMed ID: 3574287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How do acetylcholine receptor ligands reach their binding sites?
    Sáez-Briones P; Krauss M; Dreger M; Herrmann A; Tsetlin VI; Hucho F
    Eur J Biochem; 1999 Nov; 265(3):902-10. PubMed ID: 10518783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.